At least, the dependence of the content of PFN1+CD326+ CTCs on lymph node metastasis could become a prerequisite for the development of new additional criteria for determining the risk of metastasis in HNSCC patients. The gene discussed is PFN1; the disease is head and neck squamous cell carcinoma.